The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFederal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

About this trial

This study aims to assess the influence of specialized products based on ice cream on esophageal motility

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

willingness to participate based on signed written informed consent;

no qualitative changes in treatment within 6 months before enrollment (i.e., the introduction of a new antidiabetic therapy);

doses of anti-diabetic medications should be stable for 6 month in patients who receive metformin, gliptins, sulfonylureas, sodium/glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 agonists (GLP-1) or insulin.

no new medications during participation in the study

Disqualifiers

Pregnancy and breastfeeding;

Liver cirrhosis based on liver histology, or liver stiffness measurement (LSM > or = 14 kPa by Fibroscan), or APRI > or= 1; or BARD score > or = 2.

Diarrhea of any type (watery stool more than 3 times a day).

Chronic heart failure (I-IV class by NYHA).

Trial design

Design model

Crossover

Treatments tested in this trial

  • specialized food based on ice cream, order 1

    Other intervention

    Order of intervention: 1. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose; 2: ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin; 3: standard ice cream (12% fat)

  • specialized food based on ice cream, order 2

    Other intervention

    1. ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin; 2. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose; 3. standard ice cream (12% fat)

  • specialized food based on ice cream, order 3

    Other intervention

    1. standard ice cream (12% fat) 2. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose 3. ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Arm 1Experimental treatment 1 intervention
Group B: Arm 2Experimental treatment 1 intervention
Group C: Arm 3Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean lower esophageal sphincter resting pressure

Based on the high-resolution esophageal manometry measurement

Time frame
baseline, during the intervention
2

Distal contractile integral

Time frame
baseline, during the intervention
3

mean lower esophageal sphincter integral relaxation pressure

IRP 4

Time frame
baseline, during the intervention
4

Mean contractile front velocity

CFV

Time frame
baseline, during the intervention

Secondary outcomes

1

mean upper esophageal sphincter resting pressure

mean UES resting pressure

Time frame
baseline, during the intervention
2

Mean upper esophageal sphincter integrated relaxation pressure

Mean UES IRP 2 sec

Time frame
baseline, during the intervention
3

product organoleptic assessment

organoleptic assessment on taste, scent, colour and texture with the use of a special form based on visual-analogue scale (range: 1 - 5, where 1 is worse assessment, and 5 - favourable assessment)

Time frame
during the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.